Table 4.
Bevacizumab n = 32 |
Chemotherapy n = 32 |
p value | |
---|---|---|---|
Bleeding | 2 (6.3%) | 0 | 0.15 |
VTE (during treatment) | 2 (6.3%) | 4 (13%) | 0.39 |
Bowel obstruction | 9 (28%) | 10 (31.2%) | 0.40 |
Hypertension | 7 (22%) | 0 | 0.005 |
Fistula | 1 (3%) | 2 (6.3%) | 0.55 |